Latest Industry Insights

Technology Networks spoke to Jeff Hawkins, Dr Jerry Yeo, and Dr Abhijit Datta, to learn how the information provided by antibody tests can be used appropriately during the COVID-19 pandemic.

T cells are an important part of our immune memory and offer a wealth of valuable information about the way our bodies perceive and respond to pathogens. Learn how this information is being harnessed and applied in the fight against COVID-19.

In a study recently published in Cell Systems, a new ultra-high-throughput proteomics method was used to identify 27 blood biomarkers that distinguished COVID-19 patients with mild or severe responses. We spoke to Dr Markus Ralser to learn more about the study and how the method could potentially be used in the clinic to diagnose COVID-19 severity.

To learn about the benefits of accelerating turnaround times for genomic testing and the importance of partnering with pharma companies to develop companion diagnostics, Technology Networks spoke with Luca Quagliata, PhD, BCMAS, global director of medical affairs for Thermo Fisher Scientific.

Here, Dr Pretorius examines the use of saliva, rather than blood, in rapid diagnostic tests for malaria and how this clinically informative biofluid could help to improve healthcare in the world’s poorest regions.

As the world continues to battle through the pandemic, developing innovative strategies to expand the availability of extraction, and any other testing components that are facing supply issues, will be an ongoing requirement.

Technology Networks recently spoke to Quanterix's Kevin Hrusovsky to hear more about how the company's technology is being applied in the pursuit of a biomarker for Alzheimer's disease, a progressive neurodegenerative condition for which diagnosis often occurs after the onset of symptoms.

At a recent London Proteomics Discussion Group Meeting, Professor Roman Fischer kicked off the event by addressing the apparent "failure" of proteomics to deliver new clinical biomarkers thus far. Technology Networks sat down with Fischer to discuss spatial proteomics, and to expand on some of the key aspects of his research.

Technology Networks recently spoke with Bryan Witherbee, CEO, Ardaza, to learn more about ZIVA, a multiplex label-free biosensor platform, and discuss some of the applications it could benefit.

To learn more about plasma viscosity and how it can be measured, as well as understand how this information could potentially be used to help diagnose and treat COVID-19 patients, Technology Networks spoke with Bernie Benson, MD of Benson Viscometers.